⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RVTY News
Revvity, Inc.
Form 8-K
sec.gov
RVTY
Revvity to Hold Earnings Call on Tuesday, May 5, 2026
businesswire.com
RVTY
Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows
businesswire.com
RVTY
ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests
businesswire.com
REGN
AMGN
ABT
TMO
RVTY
MYGN
Revvity to Present at Upcoming Investor Conferences
businesswire.com
RVTY
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025
businesswire.com
RVTY
Revvity Board Declares Quarterly Dividend
businesswire.com
RVTY
Clinical Trial Analytics Services Market Analysis and Growth Forecast 2026-2032: Data Governance and Tech Innovation Transform the Global Landscape
globenewswire.com
CLVT
CTAS
ES
FTRE
INFY
INSM
IQV
LH
ORCL
PD
QGEN
RVTY
VEEV
Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance
businesswire.com
RVTY
Společnost Alamar Biosciences oznamuje, že poptávka investorů po konvertibilních dluhopisech převýšila nabídku a rozšíření vedoucího týmu USA - čeština USA - English USA - English APAC - English USA - Français USA - Deutsch
prnewswire.com
ILMN
VRTX
AMGN
PFE
MYGN
ROST
RVTY